Vitrolife AB
Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware … Read more
Vitrolife AB (VITR) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: 0.020x
Based on the latest financial reports, Vitrolife AB (VITR) has a cash flow conversion efficiency ratio of 0.020x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr160.00 Million) by net assets (Skr7.89 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Vitrolife AB - Cash Flow Conversion Efficiency Trend (2002–2025)
This chart illustrates how Vitrolife AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Vitrolife AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Vitrolife AB ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Neoen SA
PA:NEOEN
|
0.049x |
|
Zhejiang Yatai Pharmaceutical Co Ltd
SHE:002370
|
-0.006x |
|
Aluar Aluminio Argentino
BA:ALUA
|
0.098x |
|
Delong Composite Energy Group Co Ltd
SHE:000593
|
0.009x |
|
DISCOVERIE GRP PLC LS-05
F:9A5
|
N/A |
|
INVENTURUS KNOWLEDGE SO L
NSE:IKS
|
0.053x |
|
Sinopec Shanghai Petrochemical Company Limited
PINK:SPTJF
|
0.404x |
|
Jiangsu Yueda Investment Co Ltd
SHG:600805
|
0.002x |
Annual Cash Flow Conversion Efficiency for Vitrolife AB (2002–2025)
The table below shows the annual cash flow conversion efficiency of Vitrolife AB from 2002 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr7.89 Billion | Skr635.00 Million | 0.080x | +20.97% |
| 2024-12-31 | Skr13.64 Billion | Skr907.00 Million | 0.066x | +11.75% |
| 2023-12-31 | Skr12.72 Billion | Skr757.00 Million | 0.059x | +56.60% |
| 2022-12-31 | Skr16.74 Billion | Skr636.00 Million | 0.038x | +51.66% |
| 2021-12-31 | Skr15.34 Billion | Skr384.31 Million | 0.025x | -85.82% |
| 2020-12-31 | Skr2.02 Billion | Skr356.45 Million | 0.177x | -23.14% |
| 2019-12-31 | Skr1.80 Billion | Skr413.33 Million | 0.230x | -1.55% |
| 2018-12-31 | Skr1.50 Billion | Skr349.44 Million | 0.234x | -8.09% |
| 2017-12-31 | Skr1.23 Billion | Skr312.19 Million | 0.254x | +43.04% |
| 2016-12-31 | Skr1.02 Billion | Skr181.26 Million | 0.178x | -22.44% |
| 2015-12-31 | Skr844.97 Million | Skr193.53 Million | 0.229x | +10.47% |
| 2014-12-31 | Skr702.57 Million | Skr145.67 Million | 0.207x | -36.98% |
| 2013-12-31 | Skr322.60 Million | Skr106.13 Million | 0.329x | +53.14% |
| 2012-12-31 | Skr278.98 Million | Skr59.93 Million | 0.215x | +87.22% |
| 2011-12-31 | Skr343.90 Million | Skr39.46 Million | 0.115x | -22.63% |
| 2010-12-31 | Skr326.33 Million | Skr48.40 Million | 0.148x | +11.59% |
| 2009-12-31 | Skr312.07 Million | Skr41.48 Million | 0.133x | -9.19% |
| 2008-12-31 | Skr292.39 Million | Skr42.79 Million | 0.146x | +74.23% |
| 2007-12-31 | Skr253.38 Million | Skr21.29 Million | 0.084x | -22.07% |
| 2006-12-31 | Skr220.64 Million | Skr23.78 Million | 0.108x | +34.70% |
| 2005-12-31 | Skr176.45 Million | Skr14.12 Million | 0.080x | -13.96% |
| 2004-12-31 | Skr150.57 Million | Skr14.01 Million | 0.093x | -57.25% |
| 2003-12-31 | Skr143.44 Million | Skr31.20 Million | 0.218x | -30.30% |
| 2002-12-31 | Skr111.40 Million | Skr34.77 Million | 0.312x | -- |